Global Cell Division Cycle 7 Related Protein Kinase Market Status and Outlook 2018-2025

August 2018 | 135 pages | ID: GA86A9C6B89EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application / End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Eli Lilly and Company
• Millennium Pharmaceuticals Inc
• Nerviano Medical Sciences Srl
• Sierra Oncology Inc
• Takeda Pharmaceutical Company Ltd

Market by Type

• LBS-007
• MSK-777
• LY-3143921
• TAK-931
• Others

Market by Application

• Metastatic Breast Cancer
• Ovarian Cancer
• Acute Myelocytic Leukemia
• Colorectal Cancer
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Cell Division Cycle 7 Related Protein Kinase Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 LBS-007
  3.1.2 MSK-777
  3.1.3 LY-3143921
  3.1.4 TAK-931
  3.1.5 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Metastatic Breast Cancer
  4.1.2 Ovarian Cancer
  4.1.3 Acute Myelocytic Leukemia
  4.1.4 Colorectal Cancer
  4.1.5 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 LBS-007 Production by Region
    6.1.1.2 MSK-777 Production by Region
    6.1.1.3 LY-3143921 Production by Region
    6.1.1.4 TAK-931 Production by Region
    6.1.1.5 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Metastatic Breast Cancer Production by Region
    6.1.2.2 Ovarian Cancer Production by Region
    6.1.2.3 Acute Myelocytic Leukemia Production by Region
    6.1.2.4 Colorectal Cancer Production by Region
    6.1.2.5 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 LBS-007 Demand by Region
    6.2.1.2 MSK-777 Demand by Region
    6.2.1.3 LY-3143921 Demand by Region
    6.2.1.4 TAK-931 Demand by Region
    6.2.1.5 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Metastatic Breast Cancer Demand by Region
    6.2.2.2 Ovarian Cancer Demand by Region
    6.2.2.3 Acute Myelocytic Leukemia Demand by Region
    6.2.2.4 Colorectal Cancer Demand by Region
    6.2.2.5 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Eli Lilly and Company
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Millennium Pharmaceuticals Inc
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Nerviano Medical Sciences Srl
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Sierra Oncology Inc
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Takeda Pharmaceutical Company Ltd
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Cell Division Cycle 7 Related Protein Kinase Industry Dynamics & Regulations List
Table Global Cell Division Cycle 7 Related Protein Kinase Sales Revenue, Cost and Margin, 2015-2018E
Table Global Cell Division Cycle 7 Related Protein Kinase Market Status by Type 2015-2018E, in USD Million
Table Global Cell Division Cycle 7 Related Protein Kinase Market Status by Application 2015-2018E, in USD Million
Table Global Cell Division Cycle 7 Related Protein Kinase Market Status by Application 2015-2018E, in Volume
Table Global Cell Division Cycle 7 Related Protein Kinase Market by Region 2015-2018E, in USD Million
Table Global Cell Division Cycle 7 Related Protein Kinase Market Share by Region in 2018, in USD Million
Table Global Cell Division Cycle 7 Related Protein Kinase Market by Region 2015-2018E, in Volume
Table Global Cell Division Cycle 7 Related Protein Kinase Market Share by Region in 2018, in Volume
Table LBS-007 Production Value by Region 2015-2018E, in USD Million
Table LBS-007 Production Volume by Region 2015-2018E, in Volume
Table MSK-777 Production Value by Region 2015-2018E, in USD Million
Table MSK-777 Production Volume by Region 2015-2018E, in Volume
Table LY-3143921 Production Value by Region 2015-2018E, in USD Million
Table LY-3143921 Production Volume by Region 2015-2018E, in Volume
Table TAK-931 Production Value by Region 2015-2018E, in USD Million
Table TAK-931 Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Metastatic Breast Cancer Production Value by Region 2015-2018E, in USD Million
Table Metastatic Breast Cancer Production Volume by Region 2015-2018E, in Volume
Table Ovarian Cancer Production Value by Region 2015-2018E, in USD Million
Table Ovarian Cancer Production Volume by Region 2015-2018E, in Volume
Table Acute Myelocytic Leukemia Production Value by Region 2015-2018E, in USD Million
Table Acute Myelocytic Leukemia Production Volume by Region 2015-2018E, in Volume
Table Colorectal Cancer Production Value by Region 2015-2018E, in USD Million
Table Colorectal Cancer Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table LBS-007 Market Size by Region 2015-2018E, in USD Million
Table LBS-007 Market Size by Region 2015-2018E, in Volume
Table MSK-777 Market Size by Region 2015-2018E, in USD Million
Table MSK-777 Market Size by Region 2015-2018E, in Volume
Table LY-3143921 Market Size by Region 2015-2018E, in USD Million
Table LY-3143921 Market Size by Region 2015-2018E, in Volume
Table TAK-931 Market Size by Region 2015-2018E, in USD Million
Table TAK-931 Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Metastatic Breast Cancer Market Size by Region 2015-2018E, in USD Million
Table Metastatic Breast Cancer Market Size by Region 2015-2018E, in Volume
Table Ovarian Cancer Market Size by Region 2015-2018E, in USD Million
Table Ovarian Cancer Market Size by Region 2015-2018E, in Volume
Table Acute Myelocytic Leukemia Market Size by Region 2015-2018E, in USD Million
Table Acute Myelocytic Leukemia Market Size by Region 2015-2018E, in Volume
Table Colorectal Cancer Market Size by Region 2015-2018E, in USD Million
Table Colorectal Cancer Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalCell Division Cycle 7 Related Protein Kinase Forecast by Type 2019F-2025F, in USD Million
Table Cell Division Cycle 7 Related Protein Kinase Forecast by Type 2019F-2025F, in Volume
Table Cell Division Cycle 7 Related Protein Kinase Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Cell Division Cycle 7 Related Protein Kinase Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Cell Division Cycle 7 Related Protein Kinase Market Forecast by Region 2019F-2025F, in USD Million
Table Cell Division Cycle 7 Related Protein Kinase Market Forecast by Region 2019F-2025F, in Volume
Table Eli Lilly and Company Information
Table Cell Division Cycle 7 Related Protein Kinase Sales, Cost, Margin of Eli Lilly and Company
Table Millennium Pharmaceuticals Inc Information
Table Cell Division Cycle 7 Related Protein Kinase Sales, Cost, Margin of Millennium Pharmaceuticals Inc
Table Nerviano Medical Sciences Srl Information
Table Cell Division Cycle 7 Related Protein Kinase Sales, Cost, Margin of Nerviano Medical Sciences Srl
Table Sierra Oncology Inc Information
Table Cell Division Cycle 7 Related Protein Kinase Sales, Cost, Margin of Sierra Oncology Inc
Table Takeda Pharmaceutical Company Ltd Information
Table Cell Division Cycle 7 Related Protein Kinase Sales, Cost, Margin of Takeda Pharmaceutical Company Ltd
Table Global Cell Division Cycle 7 Related Protein Kinase Sales Revenue by Company 2015-2017, in USD Million
Table Global Cell Division Cycle 7 Related Protein Kinase Sales Volume by Company 2015-2017, in Volume
Table Global Cell Division Cycle 7 Related Protein Kinase Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Cell Division Cycle 7 Related Protein Kinase Picture
Figure Cell Division Cycle 7 Related Protein Kinase Industry Chain Diagram
Figure Global Cell Division Cycle 7 Related Protein Kinase Sales Revenue 2015-2018E, in USD Million
Figure Global Cell Division Cycle 7 Related Protein Kinase Sales Volume 2015-2018E, in Volume
Figure Global Cell Division Cycle 7 Related Protein Kinase Market Status by Type 2015-2018E, in Volume
Figure North America Cell Division Cycle 7 Related Protein Kinase Market Size and Growth 2015-2018E, in USD Million
Figure North America Cell Division Cycle 7 Related Protein Kinase Market Size and Growth 2015-2018E, in Volume
Figure Europe Cell Division Cycle 7 Related Protein Kinase Market Size and Growth 2015-2018E, in USD Million
Figure Europe Cell Division Cycle 7 Related Protein Kinase Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Cell Division Cycle 7 Related Protein Kinase Market Size and Growth 2015-2018E, in Volume
Figure South America Cell Division Cycle 7 Related Protein Kinase Market Size and Growth 2015-2018E, in USD Million
Figure South America Cell Division Cycle 7 Related Protein Kinase Market Size and Growth 2015-2018E, in Volume
Figure Middle East Cell Division Cycle 7 Related Protein Kinase Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Cell Division Cycle 7 Related Protein Kinase Market Size and Growth 2015-2018E, in Volume
Figure Africa Cell Division Cycle 7 Related Protein Kinase Market Size and Growth 2015-2018E, in USD Million
Figure Africa Cell Division Cycle 7 Related Protein Kinase Market Size and Growth 2015-2018E, in Volume
Figure Global Cell Division Cycle 7 Related Protein Kinase Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Cell Division Cycle 7 Related Protein Kinase Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Cell Division Cycle 7 Related Protein Kinase Sales Price Forecast 2019F-2025F
Figure Global Cell Division Cycle 7 Related Protein Kinase Gross Margin Forecast 2019F-2025F
Figure Global Cell Division Cycle 7 Related Protein Kinase Sales Revenue by Company in 2018, in USD Million
Figure Global Cell Division Cycle 7 Related Protein Kinase Price by Company in 2018
Figure Global Cell Division Cycle 7 Related Protein Kinase Gross Margin by Company in 2018